1. 2766 Safety of bevacizumab-containing neoadjuvant therapy followed by interval debulking surgery in advanced ovarian cancer: Data from the ANTHALYA trial. (September 2015) Authors: Selle, F.; Gouy, S.; Lambaudie, E.; Guyon, F.; Fourchotte, V.; Pomel, C.; Colombo, P.E.; Kalbacher, E.; Martin-Francoise, S.; Fauvet, R.; Follana, P.; Lesoin, A.; Lecuru, F.; Menguy, V.; Ghazi, Y.; Chereau, E.; Zohar, S.; Cottu, P.; Joly, F.; Rouzier, R. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S553 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 2772 Circulating tumor cells kinetics in ovarian carcinoma: correlation with baseline characteristics and CA-125 levels in the randomized ANTHALYA trial evaluating bevacizumab in the neoadjuvant setting. (September 2015) Authors: Cottu, P.; Rouge, T. De La Motte; Pautier, P.; Provansal, M.; Floquet, A.; Selle, F.; Mouret-Reynier, M.A.; Fabbro, M.; Kalbacher, E.; Piprot, C.; Follana, P.; Lesoin, A.; Medioni, J.; Menguy, V.; Ghazi, Y.; Bidard, F.C.; Dubot, C.; Joly, F. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S555 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 3432 Metronomic cyclophosphamide (MC) treatment for heavily pre-treated metastatic Soft Tissue Sarcoma (mSTS). (September 2015) Authors: Simon, P.; Calcagno, F.; Klajer, E.; Meynard, G.; Delroeux, D.; Aubry, S.; Pauchot, J.; Valmary-Degano, S.; Nerich, V.; Kalbacher, E.; Isambert, N.; Chaigneau, L. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S698 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗